Inc. reported its earnings for the second quarter of fiscal year 2025, surpassing expectations with an earnings per share (EPS) of $0.20 against a forecast of $0.18. The company's revenue reached $282.

Shares of Bio-Techne Corporation (NASDAQ:TECH) traded higher after the life sciences company topped analysts' expectations with its Q2 FY25 results, indicating a faster topline growth amid early signs of recovery in the biopharma end market.

For the current quarter ending in March, Alpha and Omega said it expects revenue in the range of $148 million to $168 million. Alpha and Omega shares have increased 17% since the beginning of the year.

The average estimate of four analysts surveyed by Zacks Investment Research was also for earnings of 25 cents per share.

For the current quarter ending in March, Affirm Holdings said it expects revenue in the range of $755 million to $785 million. The company expects full-year revenue in the range of $3.13 billion to $3.